National Health Investors Inc. (NYSE:NHI)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $80.47 and last traded at $80.44, with a volume of 165,895 shares. The stock had previously closed at $79.65.

A number of equities research analysts have weighed in on the company. JMP Securities restated a “hold” rating on shares of National Health Investors in a research report on Saturday, June 4th. Zacks Investment Research downgraded National Health Investors from a “buy” rating to a “sell” rating in a research report on Wednesday, August 3rd. Mizuho upped their target price on National Health Investors from $66.00 to $77.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Finally, Cantor Fitzgerald restated a “hold” rating on shares of National Health Investors in a research report on Thursday, August 18th. Five analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $72.50.

The company’s 50 day moving average price is $77.93 and its 200 day moving average price is $69.81. The company has a market capitalization of $3.18 billion and a P/E ratio of 18.72.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Friday, August 5th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.01. The business earned $61.20 million during the quarter, compared to analyst estimates of $58.08 million. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.17 earnings per share. Analysts forecast that National Health Investors Inc. will post $4.87 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 10th. Stockholders of record on Friday, September 30th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Wednesday, September 28th. This represents a $3.60 annualized dividend and a dividend yield of 4.44%.

In other National Health Investors news, Director Robert A. Mccabe, Jr. sold 1,250 shares of the business’s stock in a transaction dated Monday, June 13th. The shares were sold at an average price of $71.61, for a total value of $89,512.50. Following the completion of the sale, the director now owns 9,736 shares of the company’s stock, valued at approximately $697,194.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kristin Sallee Gaines sold 8,652 shares of the business’s stock in a transaction dated Wednesday, June 29th. The shares were sold at an average price of $73.98, for a total transaction of $640,074.96. Following the completion of the sale, the insider now directly owns 53,089 shares of the company’s stock, valued at approximately $3,927,524.22. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in National Health Investors stock. Westfield Capital Management Co. LP boosted its position in National Health Investors Inc. (NYSE:NHI) by 81.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 436,425 shares of the real estate investment trust’s stock after buying an additional 195,807 shares during the period. Westfield Capital Management Co. LP owned approximately 1.16% of National Health Investors worth $26,565,000 as of its most recent filing with the SEC.

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.